HPE
46
-5
ESS
59
5
EW
34
2
PEG
55
2
PVH
50
-3
VRSN
54
-2
AAP
29
2
O
50
2
XEL
57
4
TAP
63
2
WU
12
2
WHR
50
-3
RHI
53
5
BWA
55
3
ROP
45
-5
SCHW
61
2
LNC
58
-5
WEC
50
4
KHC
40
-3
EQR
62
3
HPE
46
-5
ESS
59
5
EW
34
2
PEG
55
2
PVH
50
-3
VRSN
54
-2
AAP
29
2
O
50
2
XEL
57
4
TAP
63
2
WU
12
2
WHR
50
-3
RHI
53
5
BWA
55
3
ROP
45
-5
SCHW
61
2
LNC
58
-5
WEC
50
4
KHC
40
-3
EQR
62
3
Financhill
Back

Zimmer Biomet Holdings 10K Form

Sell
44

ZBH
Zimmer Biomet Holdings

Last Price:
103.99
Seasonality Move:
4.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZBH News And Ratings

See the #1 stock for the next 7 days that we like better than ZBH

ZBH Financial Statistics

Sales & Book Value

Annual Sales: $7.39B
Cash Flow: $192.2M
Price / Cash Flow: 19.49
Annual Sales: $62.18
Price / Book: 1.67

Profitability

EPS (TTM): 4.80000
Net Income (TTM): $997.1M
Gross Margin: $5.31B
Return on Equity: 7.95%
Return on Assets: 4.66%

Zimmer Biomet Holdings Earnings Forecast

Key Zimmer Biomet Holdings Financial Ratios

  • The Gross Profit Margin over the past 24 years for ZBH is 71.82%.
  • The Selling, General & Administrative Expenses for ZBH have been equal to 38.39% of Gross Profit Margin.
  • The Research & Development expenses have been 6.20% of Revenue.
  • The Interest Expense is 19.65% of Operating Income.
  • The Net Earning history of ZBH is 13.85% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Zimmer Biomet Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ZBH
CUSIP: 98956P
Website: zimmerbiomet.com

Debt

Debt-to-Equity Ratio: 0.46
Current Ratio: 1.29
Quick Ratio: 0.51

Price-to-Earnings

Trailing P/E Ratio: 21.36
Forward P/E Ratio: 12.17

ZBH Technical Analysis vs Fundamental Analysis

Sell
44
Zimmer Biomet Holdings (ZBH) is a Sell

Is Zimmer Biomet Holdings a Buy or a Sell?